Université Catholique de Louvain
uclouvain.beLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
146
Active
47
Phase 3
1
Total enrollment
32,858
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Arterial blood sample | — | — | — | — | — | 2 |
Next readouts
- 2028-01
- 2029-01
Top conditions
- Healthy14
- Cerebral Palsy11
- Stroke4
- Rheumatoid Arthritis4
- Depression3
- Parkinson Disease3
- Cachexia3
- Low Back Pain3
Frequently asked questions about Université Catholique de Louvain
- How many clinical trials does Université Catholique de Louvain have on ClinicalTrials.gov?
- Université Catholique de Louvain is listed as the lead sponsor on 146 clinical trials in ClinicalTrials.gov, 47 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Université Catholique de Louvain's trials are in Phase 3?
- 1 of Université Catholique de Louvain's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Université Catholique de Louvain focus on?
- Université Catholique de Louvain's most-studied conditions on ClinicalTrials.gov are Healthy, Cerebral Palsy, Stroke, Rheumatoid Arthritis, Depression.
- When are Université Catholique de Louvain's next clinical trial readouts?
- Université Catholique de Louvain has 2 upcoming primary-completion readouts tracked here; the soonest is “Assessment of GARP Expression in Acute and Chronic Coronary Syndrome”, expected around 2028-01.